Vendor review
Mai Peptides (mai-peptides.com) reviews
Mai Peptides (mai-peptides.com) reviews from 121 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is Mai Peptides (mai-peptides.com) legit? See what its vials showed.
What the lab tests show
121 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 6, 2026 | Tirzepatide | 99.9 % | 55.9 mg of 60 mg (-7 %) | Pass | View |
| Oct 1, 2026 | GHK-Cu | 99.9 % | 49.99 mg of 50 mg (0 %) | Pass | View |
| Sep 29, 2026 | GHK-Cu | 100 % | 129.677 mg of 100 mg (30 %) | Pass | View |
| Sep 25, 2026 | Tirzepatide | 91.1 % | 20.6 mg of 20 mg (3 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.9 % | 51.1 mg of 60 mg (-15 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 5 mg | Fail | View | |
| Sep 24, 2026 | Retatrutide | 99.9 % | 13.1 mg of 15 mg (-13 %) | Pass | View |
| Sep 19, 2026 | GHK-Cu | 99.7 % | 102.8 mg of 100 mg (3 %) | Pass | View |
| Sep 19, 2026 | Ipamorelin | 99.99 % | 13.11 mg of 10 mg (31 %) | Pass | View |
| Sep 18, 2026 | Retatrutide | 99.99 % | 12.71 mg of 10 mg (27 %) | Pass | View |
| Sep 18, 2026 | Tesamorelin | 99.9 % | 9.22 mg of 10 mg (-8 %) | Pass | View |
| Sep 18, 2026 | Tirzepatide | 99.99 % | 29.86 mg of 30 mg (0 %) | Pass | View |
| Sep 18, 2026 | TB-500 | 10 mg | Fail | View | |
| Sep 18, 2026 | CJC-1295 | 99.99 % | 11.9 mg of 10 mg (19 %) | Pass | View |
| Sep 18, 2026 | Semaglutide | 5 mg | Fail | View | |
| Sep 16, 2026 | Tesamorelin | 99.6 % | 5.6 mg of 5 mg (12 %) | Pass | View |
| Sep 15, 2026 | Retatrutide | 99.9 % | 15.1 mg of 15 mg (1 %) | Pass | View |
| Sep 7, 2026 | Tirzepatide | 99.8 % | 11.9 mg of 10 mg (19 %) | Pass | View |
| Sep 4, 2026 | Tirzepatide | 99.9 % | 30.1 mg of 30 mg (0 %) | Pass | View |
| Aug 27, 2026 | BPC-157 | 91.8 % | 11.61 mg of 10 mg (16 %) | Pass | View |
| Aug 25, 2026 | GHK-Cu | 82.9 % | 88.1 mg of 100 mg (-12 %) | Pass | View |
| Aug 25, 2026 | Retatrutide | 99.9 % | 60.4 mg of 60 mg (1 %) | Pass | View |
| Aug 21, 2026 | Tirzepatide | 50 mg | Fail | View | |
| Jul 30, 2026 | Tirzepatide | 40 mg | Fail | View | |
| Jul 30, 2026 | GHK-Cu | 67.9 % | 39.6 mg of 50 mg (-21 %) | Pass | View |
| Jul 30, 2026 | BPC-157 | 20 mg | Fail | View | |
| Jul 30, 2026 | TB-500 | 10 mg | Fail | View | |
| Jul 13, 2026 | Cagrilintide | 99.7 % | 5.65 mg of 5 mg (13 %) | Pass | View |
| Jul 13, 2026 | BPC-157 | 99.9 % | 4.74 mg of 5 mg (-5 %) | Pass | View |
| Jul 13, 2026 | Tesamorelin | 98.1 % | 5.63 mg of 5 mg (13 %) | Pass | View |
| Jul 10, 2026 | Retatrutide | 99.6 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Jul 1, 2026 | Tirzepatide | 99.9 % | 32.1 mg of 30 mg (7 %) | Pass | View |
| Jul 1, 2026 | GHK-Cu | 99.9 % | 44.2 mg of 50 mg (-12 %) | Pass | View |
| Jul 1, 2026 | BPC-157 | 97.4 % | 4.89 mg of 5 mg (-2 %) | Pass | View |
| Jul 1, 2026 | Retatrutide | 99.9 % | 27.4 mg of 30 mg (-9 %) | Pass | View |
| Jul 1, 2026 | NAD+ | 99.9 % | 87.4 mg of 100 mg (-13 %) | Pass | View |
| Jun 26, 2026 | GHK-Cu | 99.7 % | 74.2 mg of 100 mg (-26 %) | Pass | View |
| Jun 24, 2026 | NAD+ | 99.1 % | 569 mg of 500 mg (14 %) | Pass | View |
| Jun 16, 2026 | NAD+ | 98.9 % | 534 mg of 500 mg (7 %) | Pass | View |
| Jun 8, 2026 | Tirzepatide | 99.8 % | 39.3 mg of 30 mg (31 %) | Pass | View |
| Jun 5, 2026 | Retatrutide | 99.9 % | 29.9 mg of 30 mg (0 %) | Pass | View |
| May 13, 2026 | Retatrutide | 99.9 % | 30 mg of 30 mg (0 %) | Pass | View |
| May 13, 2026 | Retatrutide | 99.9 % | 47.3 mg of 50 mg (-5 %) | Pass | View |
| Apr 28, 2026 | BPC-157 | 10 mg | Fail | View | |
| Apr 28, 2026 | Ipamorelin | 99.9 % | 5.34 mg of 5 mg (7 %) | Pass | View |
| Apr 28, 2026 | CJC-1295 | 99.9 % | 5.06 mg of 5 mg (1 %) | Pass | View |
| Mar 13, 2026 | Retatrutide | 99.66 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Mar 13, 2026 | Retatrutide | 99.8 % | 21.6 mg of 20 mg (8 %) | Pass | View |
| Mar 12, 2026 | Tesamorelin | 99.9 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Mar 12, 2026 | Retatrutide | 99.9 % | 43.8 mg of 50 mg (-12 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 51.7 mg of 60 mg (-14 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 42.4 mg of 50 mg (-15 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 37.9 mg of 40 mg (-5 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 70.2 mg of 60 mg (17 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 52.4 mg of 50 mg (5 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 99.06 % | 25.3 mg of 30 mg (-16 %) | Pass | View |
| Mar 3, 2026 | Semaglutide | 98.17 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Mar 1, 2026 | Cagrilintide | 98.8 % | 4.9 mg of 5 mg (-2 %) | Pass | View |
| Feb 26, 2026 | BPC-157 | 99.73 % | 9.73 mg of 10 mg (-3 %) | Pass | View |
| Feb 22, 2026 | Retatrutide | 99.9 % | 40.1 mg of 40 mg (0 %) | Pass | View |
What Mai Peptides sells
No current listings on record.
About Mai Peptides
https://www.maipeptide.com/